![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Pharmacosmos A/s Holbaek Dk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Dextran 60 for injection, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 1999-064 - Rev 03
This Chemical Type CEP, issued on January 03, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1000 associated with this CEP further emphasizes